Boston Scientific Scimed, Inc.

Scimed Life Systems, Inc.

Boston Scientific Corporation

Astora Women's Health, LLC

David John Sogard

Scott Raymond Smith

Jason P Hill

Susan M Shoemaker

Anthony Ciro Vrba

Lance A Monroe

Kent David Harrison

Patrick A Haverkost

Christopher Brian Brodeur

Lixiao Wang

Liliana Atanasoska

Timothy Samuel Girton

Leonard B Richardson

Jan Weber

Mark Lynn Jenson

Aiden Flanagan

Gary L Hendrickson

Joel R Munsinger

Andrew D Bicek

Liza J Davis

Bruce A Parsons

Howard Wolek

Diane M Sheahen

James Venditti

Alice Wong

Joel Phillips

William Joseph Drasler

Thomas J Holman

Daniel O Adams

John J Allen

James Ryan Mujwid

Graig Leonard Kveen

Robert Warner

Tracee E J Eidenschink

Kevin R Arnal

Michael J Root

Jessica Elizabeth Felton

Joel M Wasdyke

James Q Feng

Eric Michael Petersen

Rajesh Radhakrishnan

Douglas R Saholt

David Tseng

Mourad Rahi

Bruce H Rau

Susan A Shoemaker

Scott Savitt

Pete T Keith

Mark L Jensen

Christopher B Brodeur

Scott Smith

Tracee EJ Eidenschink

Kent D Harrison

Jason Peter Hill

A composite biomaterial having a continuous metal sheet with arcuate members that define a first fenestration pattern, and a polymer layer over at least one surface of the continuous metal sheet. The arcuate members elastically stretch to allow the continuous metal sheet to bend in more than one axis without buckling or wrinkling.

Synthetic composite structures

Systems and methods are provided and adapted to engage and pull (e.g., pull up) or reposition urethral support tissue, such as the portion of the perineal membrane above or below the urethra. The perineal membrane intersects the urethra and vagina at the midurethra or distal location and can thus be stabilized or controlled in a manner that helps restore continence.

Pelvic implant system and method

An elongated flexible medical device is inserted into a patient's body via a natural orifice, and advanced through the natural orifice to a location proximate innervated tissue that influences renal sympathetic nerve activity. The medical device can be advanced into a body organ and to a location within the organ proximate the innervated tissue. The organ may comprise an organ of the gastrointestinal tract or urinary tract. The medical device may be advanced through and beyond an access hole in a wall of the organ, and situated at a location proximate the innervated tissue. One or both of imaging and ablation energy is delivered from a distal end of the medical device to the innervated tissue. Innervated renal tissue can be ablated using various forms of energy, including RF energy, ultrasound energy, optical energy, and thermal energy.

Minimally invasive access for renal nerve ablation

This disclosure pertains to controllably bioabsorbable devices, particularly anchors for vascular closure plugs and to methods of use thereof.

Vascular closure device with biodegradable anchor

An electrode is provided at a distal end of a catheter and dimensioned for deployment within a renal artery. A deformable cover of the electrode incorporates a force-activatable conduction apparatus. The cover is configured to conduct electrical energy only through a region or regions of the cover subject to deformation due to contact with a wall of the target vessel. The electrical energy is sufficient to ablate perivascular renal nerves proximate the deformed region or regions of the electrode cover. The cover is configured to prevent conduction of electrical energy through the cover in the absence of a deformation force applied to the cover.

Renal ablation electrode with force-activatable conduction apparatus

An intravascular filter for a vessel includes a non-biodegradable apical hub and non-biodegradable struts extending generally distally from the hub. The struts extend radially outward from a longitudinal axis of the hub. The distal ends of the struts exert an expansile force against an interior of the vessel. One or more struts includes one or more time-degrading connectors along its length, which can be formed from a biodegradable element made from a fixation material. Prior to degradation, the fixation material rigidly connects a proximal section to a distal section of the respective strut. After degradation, the fixation material is dissolved or softened, and reveals a link that has a strong resistance to longitudinal movement of the distal section with respect to the proximal section and may have a weak resistance to rotational movement of the distal section with respect to the proximal section, such as a pair of interlocked loops.

Intravascular filter with biodegradable force-reducing element

A valve with a structural member and valve leaflets that provide a sinus.

Valve with sinus

A system for delivering therapeutic agent to a target location in a body in accordance with one embodiment is provided comprising a plurality of magnetic particles, each magnetic particle carrying a therapeutic agent, and a magnetic device for attracting the magnetic particles to a target location. The magnetic particles may be delivered by a catheter into a blood vessel upstream from the target location so that they travel toward the target location. A method for delivering therapeutic agent to a target location in a body in accordance with another embodiment comprises providing a plurality of magnetic particles, each magnetic particle carrying a therapeutic agent, placing a magnetic device in a position to attract the magnetic particles to a target location, and allowing the magnetic particles to infuse the target location by the attraction of the magnetic particles to the magnetic device. The therapeutic agent may comprises a therapeutic agent for preventing or treating reperfusion injury, and the step of providing the plurality of magnetic particles may comprise delivering the plurality of magnetic particles through a blood vessel.

Magnetic particles for delivering therapeutic agent to a target location

In one embodiment, the present disclosure provides a biodegradable, self-powered medical device for preventing or reducing reperfusion injury, comprising a galvanic cell, the galvanic cell comprising: a first biodegradable electrode member; and a second biodegradable electrode member comprising a biodegradable conductive polymer and an electrode-releasable therapeutic agent, wherein the galvanic cell generates an electric force sufficient to cause the electrode-releasable therapeutic agent to be released from the biodegradable conductive polymer and elute to a target location. The device may further include a reservoir material containing a burst-release therapeutic agent.

Implantable self-powered biodegradable medical device to treat or prevent reperfusion injury

A medical device delivery system, having a rolling retractable sheath covering a medical device mounting region on the system is disclosed. The rolling retractable sheath comprises an inner wall and an outer wall and may be formed of one or more materials, optionally porous. Optionally, a lubricant may be applied selectively to the interior and exterior walls of the stent.

Rolling membrane stent delivery system

Methods, apparatus, and systems for occluding a multiplicity of parallel membranes, such as found in a patent foramen ovale (PFO). Methods, apparatus, and systems include the use of a positioning device that can be seated on the limbus of the septum secundum (SS). The positioning device includes a piercing member that can pierce the SS and septum primum (SP). The positioning device also includes a fastening member that can engage the SS and SP to fasten the tissues and occlude a PFO.

Defect occlusion apparatus, system, and method

The present disclosure relates generally to devices, systems, and methods for use with tissue, more particularly the present disclosure relates to a device including a frame with a surface defining a pinch point region with a predefined shape. The device also includes a tab with an opening defining an anchor attachment on the frame. The frame can elastically deform under a stress to alter the predefined shape of the pinch point region.

Tissue attachment device, system, and method

Methods, apparatus, and systems for locating a patent foramen ovale (PFO) with a positioning device that can be configured to occlude the PFO. Methods, apparatus, and systems include the use of a positioning device that can be seated on the limbus of a septum secundum (SS). The positioning device includes a piercing member that can pierce the SS and a septum primum.

Transeptal apparatus, system, and method

Methods, apparatus, and systems for altering the configuration of a heart valve. Methods, apparatus, and systems include the use of a cord delivered into the heart by a delivery catheter that can be manipulated by a receiving catheter so as to improve the heart valve function.

Translumenal apparatus, system, and method

Growing community of inventors

Edina, MN, United States of America

David John Sogard